33 results
8-K
BTAX
Biostax Corp.
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
Disclosure.
The issuer has filed a lawsuit in the United States District Court for the Eastern District of Virginia (Immune Therapeutics, Inc. v
S-8
BTAX
Biostax Corp.
15 Oct 18
Registration of securities for employees
9:22am
, including a lawsuit, because of their position. We must advance expenses incurred in defending a proceeding. The person to be indemnified must have acted
8-K
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
, the Company was joined in filing a Chapter 11 involuntary bankruptcy lawsuit in the United States Bankruptcy Court in the District of Colorado (Denver
8-K
EX-10.1
t68w44d
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
10-12G
rj7gezbhwoc tdcr9
22 Apr 13
Registration of securities
12:00am
10-12G/A
5ntca9u148t29
7 Jun 13
Registration of securities (amended)
12:00am
10-K
6cqp0od3xk6 s2x2nb5
31 Mar 14
Annual report
12:00am